71 related articles for article (PubMed ID: 8488339)
1. Anti-Candida activity of the anti-cancer drug tamoxifen.
Beggs WH
Res Commun Chem Pathol Pharmacol; 1993 Apr; 80(1):125-8. PubMed ID: 8488339
[TBL] [Abstract][Full Text] [Related]
2. Growth phase in relation to the lethal action of tamoxifen on Candida albicans.
Beggs WH
Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):115-8. PubMed ID: 7620832
[TBL] [Abstract][Full Text] [Related]
3. Potential fungicidal effect of voriconazole against Candida spp.
Rubio MC; de Ocáriz IR; Gil J; Benito R; Rezusta A
Int J Antimicrob Agents; 2005 Mar; 25(3):264-7. PubMed ID: 15737524
[TBL] [Abstract][Full Text] [Related]
4. Lovastatin possesses a fungistatic effect against Candida albicans, but does not trigger apoptosis in this opportunistic human pathogen.
Gyetvai A; Emri T; Takács K; Dergez T; Fekete A; Pesti M; Pócsi I; Lenkey B
FEMS Yeast Res; 2006 Dec; 6(8):1140-8. PubMed ID: 17156011
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical modification of the excretion product of Saccharomyces cerevisiae killer strains results in fungicidal activity against Candida albicans and Tricophyton mentagrophytes.
Bracesco N; Salvo VA; Carrau FM; Nunes E
FEMS Microbiol Lett; 2006 Mar; 256(1):132-6. PubMed ID: 16487330
[TBL] [Abstract][Full Text] [Related]
6. [Appraisal of fungistatic and fungicidal activities of quaternary compounds towards yeasts belonging to the genera Candida and Cryptococcus].
Mathieu G; Delcourt A
Ann Pharm Fr; 2001 Apr; 59(2):125-9. PubMed ID: 11320337
[TBL] [Abstract][Full Text] [Related]
7. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model.
Lignell A; Löwdin E; Cars O; Sjölin J
J Antimicrob Chemother; 2008 Jul; 62(1):142-8. PubMed ID: 18408237
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans.
Jainkittivong A; Butsarakamruha T; Langlais RP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):394-8. PubMed ID: 19716507
[TBL] [Abstract][Full Text] [Related]
10. Anethole, a potential antimicrobial synergist, converts a fungistatic dodecanol to a fungicidal agent.
Fujita K; Fujita T; Kubo I
Phytother Res; 2007 Jan; 21(1):47-51. PubMed ID: 17078111
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal activity of 2,5 disubstituted amino-oksometyloso-arylo-thiadiazole derivatives.
Lukaszuk C; Krajewska-Kułak E; Niewiadomy A; Stachowicz J; Głaszcz U; Oksiejczuk E
Adv Med Sci; 2007; 52 Suppl 1():26-9. PubMed ID: 18229628
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
14. Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.
Arai R; Sugita T; Nishikawa A
Mycoses; 2005 Jan; 48(1):38-41. PubMed ID: 15679664
[TBL] [Abstract][Full Text] [Related]
15. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
[TBL] [Abstract][Full Text] [Related]
16. Fungicidal effect of three new synthetic cationic peptides against Candida albicans.
Nikawa H; Fukushima H; Makihira S; Hamada T; Samaranayake LP
Oral Dis; 2004 Jul; 10(4):221-8. PubMed ID: 15196144
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of the fungicidal activity of amphotericin B by allicin, an allyl-sulfur compound from garlic, against the yeast Saccharomyces cerevisiae as a model system.
Ogita A; Fujita K; Taniguchi M; Tanaka T
Planta Med; 2006 Oct; 72(13):1247-50. PubMed ID: 16902870
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and fungicidal activity of 3,5-dichloropyrazin-2(1H)-one derivatives.
François IE; Cammue BP; Bresseleers S; Fleuren H; Hoornaert G; Mehta VP; Modha SG; Van der Eycken EV; Thevissen K
Bioorg Med Chem Lett; 2009 Aug; 19(15):4064-6. PubMed ID: 19556127
[TBL] [Abstract][Full Text] [Related]
19. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; López-Ribot JL
Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
[TBL] [Abstract][Full Text] [Related]
20. Antifungal mechanisms supporting boric acid therapy of Candida vaginitis.
De Seta F; Schmidt M; Vu B; Essmann M; Larsen B
J Antimicrob Chemother; 2009 Feb; 63(2):325-36. PubMed ID: 19059942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
